Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-07

FDA Approved: TERIPARATIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approves Apotex Corp.'s supplemental application for a generic teriparatide product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)

Snippet

SUPPL AP for TERIPARATIDE (TERIPARATIDE)